STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on June 11, 2026

3 hours ago

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

Indeterminate GlobeNewswire

3 hours ago

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease

Indeterminate GlobeNewswire

3 hours ago

Clinical Data Showed Average 67% Pain Score Reduction and 50% Gain in Walking Distance with Cartigenix HP® in 90 Days*†

Indeterminate GlobeNewswire

3 hours ago

Impact Analytics Honored as 2026 “Demand Forecasting Solution of the Year” for the Second Consecutive Year, by SupplyTech Breakthrough

Indeterminate GlobeNewswire

3 hours ago

BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026

Indeterminate GlobeNewswire

3 hours ago

Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program

Indeterminate GlobeNewswire

3 hours ago

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline

Indeterminate GlobeNewswire

3 hours ago

Joveo Named Strategic Challenger on 2026 Fosway 9-Grid™ for Talent Acquisition

Indeterminate GlobeNewswire

3 hours ago

BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return

Indeterminate GlobeNewswire

3 hours ago

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

Indeterminate GlobeNewswire

3 hours ago

Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

3 hours ago

Verano Completes 1-for-5 Reverse Stock Split, Advancing the Company’s Path Towards Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

3 hours ago

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

Indeterminate GlobeNewswire

3 hours ago

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

Indeterminate GlobeNewswire

3 hours ago

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Indeterminate GlobeNewswire

3 hours ago

Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology

Indeterminate GlobeNewswire

3 hours ago

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

Indeterminate GlobeNewswire

3 hours ago

Pharvaris Announces Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

3 hours ago

MSX Launches X Card, Bridging Digital Assets and Global Consumer Payments

Indeterminate GlobeNewswire

3 hours ago

BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.76 Billion in 2026

Indeterminate GlobeNewswire